ClassID:

21477

A61K49/08 - CPC Classification

Classification description:

Preparations for testing; Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier

Sub-classes:
Recent Application in this class:
#1
20250276099
2025-09-04

MRI CONTRAST AGENT INCLUDING T1 CONTRAST MATERIAL COATED ON SURFACE OF NANOPARTICLE SUPPORT

#2
20250241871
2025-07-31

METHOD FOR MAKING A CURCUMINOID-CONTAINING DRUG DELIVERY COMPOSITION

#3
20250144252
2025-05-08

CARBON NANOPARTICLE SUSPENSION INJECTION-FE, PREPARATION METHOD, APPLICATION AND USE METHOD

#4
20240190897
2024-06-13

NITROGEN-CONTAINING MACROCYCLIC CONJUGATES AS RADIOPHARMACEUTICALS

#5
20240100197
2024-03-28

Method for making superparamagnetic iron oxide nanocarrier

#6
20230390419
2023-12-07

Equilibrium adsorption method for making a silica nanocarrier spion composition

#7
20230293722
2023-09-21

Compositions and Methods for Treating Neurological-associated Disorders

#8
20230109491
2023-04-06

EDB-FN AS BIOMARKER OF CANCER AND/OR BRAIN DISEASE AND NANODRUG DELIVERY SYSTEM TARGETING SAME

#9
20230068832
2023-03-02

Curcuminoid chemotherapeutic drug carrier composition

#10
20230046343
2023-02-16

Method for treating breast cancer with a chemotherapeutic drug carrier

#11
20230036453
2023-02-02

System and Method for Microfluidic Parahydrogen Induced Polarization Hyperpolarizer for Magnetic Resonance Imaging (MRI) and Nuclear Magnetic Resonance (NMR) Applications

#12
20220226512
2022-07-21

MACROPHAGE IMAGING AGENT

#13
20220054661
2022-02-24

Assessment of coronary heart disease with carbon dioxide

#14
20210363161
2021-11-25

Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals

#15
20210322580
2021-10-21

Nanosilica carrier with spions and a curcuminoid

#16
20210113717
2021-04-22

MRI CONTRAST AGENT INCLUDING T1 CONTRAST MATERIAL COATED ON SURFACE OF NANOPARTICLE SUPPORT

#17
20210106698
2021-04-15

LIVER-SPECIFIC MRI CONTRAST AGENT INCLUDING MANGANESE SILICATE NANOPARTICLES

#18
20210078867
2021-03-18

Method for synthesizing silica nanoparticles

#19
20200268911
2020-08-27

Method to detect brain functional activities using hyperpolarized 129Xe MR

#20
20200198977
2020-06-25

GRAPHENE-SUPPORTED METAL AND/OR METAL OXIDE NANOPARTICLE COMPOSITES, METHOD FOR MAKING SAME AND USES THEREOF

#21
20200138981
2020-05-07

Biomedical materials

#22
20200115391
2020-04-16

Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals

#23
20200038525
2020-02-06

Curcumin-based magnetic nanostructured system for dual response of imaging and therapeutics

#24
20190257904
2019-08-22

Systems and methods for polarized nuclear imaging and spectroscopy

#25
20190225625
2019-07-25

Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals

#26
20190204397
2019-07-04

System and method for microfluidic parahydrogen induced polarization hyperpolarizer for magnetic resonance imaging (MRI) and nuclear magnetic resonance (NMR) applications

#27
20190038781
2019-02-07

Assessment of coronary heart disease with carbon dioxide

#28
20180185519
2018-07-05

ASSESSMENT OF CORONARY HEART DISEASE WITH CARBON DIOXIDE

#29
20180092994
2018-04-05

Host cells with artificial endosymbionts

#30
20180036435
2018-02-08

Dual-modality imaging probe for combined localization and apoptosis detection of stem cells

#31
20170267699
2017-09-21

Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals

#32
20170267698
2017-09-21

Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals

#33
20170136133
2017-05-18

Biomedical materials

#34
20170079581
2017-03-23

MRI-guided intraarterial catheter-based method for predicting territory of local blood brain barrier opening

#35
20170074859
2017-03-16

Graphene oxide mediated cellular delivery of gadolinium-labeled molecules

#36
20170043041
2017-02-16

Nanoparticle-enabled x-ray magnetic resonance imaging (NXMRI)

#37
20170021041
2017-01-26

Image-guided delivery of a mixture of bacteria and non-bacteria linked nanoparticles

#38
20160376670
2016-12-29

Eukaryotic cells with artificial endosymbionts for multimodal detection

#39
20160279273
2016-09-29

Microsphere comprising a lanthanide metal complex

#40
20160271274
2016-09-22

SYNTHESIS AND USE OF TARGETED RADIATION ENHANCING IRON OXIDE-SILICA-GOLD NANOSHELLS FOR IMAGING AND TREATMENT OF CANCER

#41
20160206736
2016-07-21

Ligands to radiation-induced molecules

#42
20160199518
2016-07-14

Eukaryotic cells with artificial endosymbionts for multimodal detection

#43
20160129138
2016-05-12

Octapod iron oxide nanoparticles as high performance Tcontrast agents for magnetic resonance imaging

#44
20160038727
2016-02-11

System for delivery of gaseous imaging contrast agents and methods for using same

#45
20160022485
2016-01-28

Magnetic operating microscopes and methods of treatment and diagnosis using the same

#46
20160008495
2016-01-14

Metallocene compounds and labeled molecules comprising the same for in vivo imaging

#47
20160000942
2016-01-07

MRI CONTRAST AGENT INCLUDING T1 CONTRAST MATERIAL COATED ON SURFACE OF NANOPARTICLE SUPPORT

#48
20150297757
2015-10-22

MACROPHAGE-ENHANCED MRI (MEMRI) IN A SINGLE IMAGING SESSION

#49
20150258222
2015-09-17

Magnetic nanoparticles

#50
20150258220
2015-09-17

MAGNETIC RESONANCE IMAGING AND/OR SPECTROSCOPY CONTRAST AGENTS AND METHODS OF USE THEREOF

#51
20150064107
2015-03-05

IMAGING AGENT

#52
20140369929
2014-12-18

Ligands to radiation-induced molecules

#53
20140219926
2014-08-07

Biodegradable Iron Oxide Nanoparticle Gel for Tumor Bed Therapy

#54
20140186268
2014-07-03

Oxide Ferrimagnetics with Spinel Structure Nanoparticles and Iron Oxide Nanoparticles, Biocompatible Aqueous Colloidal Systems Comprising Nanoparticles, Ferriliposomes, and Uses Thereof

#55
20130344003
2013-12-26

IMMUNO-THERAPY FOR CANCER TREATMENT USING IRON OXIDE NANOPARTICLES

#56
20130302256
2013-11-14

Nanoparticulate manganese MRI contrast agents

#57
20130295020
2013-11-07

Radiopaque embolic particles

#58
20130280165
2013-10-24

Microsphere comprising a lanthanide metal complex

#59
20130251628
2013-09-26

Ligands to radiation-induced molecules

#60
20130209369
2013-08-15

Nanoparticles based on gadolinium coordination polymers as highly sensitive T1 MRI contrast agents

#61
20130189189
2013-07-25

COMPOSITION FOR THE DIAGNOSIS, PREVENTION OR TREATMENT OF DISEASES RELATED TO CELLS EXPRESSING IL-8 OR GRO-ALPHA, COMPRISING UCB-MSCs

#62
20130142724
2013-06-06

Using Heavy Water as a Contrast Agent for Hydrogen Magnetic Resonance Imaging

#63
20130129634
2013-05-23

Intrinsically magnetic hydroxyapatite

#64
20130115172
2013-05-09

MAGNETIC NANOPHOSPHOR HAVING CORE/SHELL STRUCTURE AND THE SYNTHETIC METHOD THEREOF

#65
20120114564
2012-05-10

MRI T1 CONTRASTING AGENT COMPRISING MANGANESE OXIDE NANOPARTICLE

#66
20120003160
2012-01-05

Macrophage-Enhanced MRI (MEMRI) in a Single Imaging Session

#67
20110293517
2011-12-01

Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals

#68
20110213293
2011-09-01

Ligands to radiation-induced molecules

#69
20110195028
2011-08-11

Magnetic resonance imaging and/or spectroscopy contrast agents and methods of use thereof

#70
20110177009
2011-07-21

Drug carrier providing MRI contrast enhancement

#71
20100322867
2010-12-23

Biomedical materials

#72
20100215587
2010-08-26

Materials and methods for MRI contrast agents and drug delivery

#73
20100143261
2010-06-10

UCB-MSCs comprising a tumor suppressor gene reduce the size of an IL-8 or GRO-αexpressing tumor

#74
20100092390
2010-04-15

Methods for Making Particles Having Long Spin-Lattice Relaxation Times

#75
20090246144
2009-10-01

System and method for indirectly measuring calcium ion efflux

#76
20080274053
2008-11-06

TISSUE METABOLIC STRESS MONITORING

#77
20070086948
2007-04-19

Tissue metabolic stress monitoring

#78
20060104898
2006-05-18

Ligands to radiation-induced molecules